Omeros (OMER) Operating Expenses (2010 - 2026)
Omeros (OMER) reported Operating Expenses of $27.3 million for Q1 2026, down 21.89% on a YoY basis from $35.0 million in Q1 2025, and down 6.08% sequentially from $29.1 million in Q4 2025.
Omeros (OMER) Operating Expenses (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Operating Expenses data on file, last reported at $27.3 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses fell 21.89% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $115.1 million (down 29.31% YoY), and the FY2025 full-year result was $122.8 million, down 26.45% from the prior year.
- Operating Expenses retreated to $27.3 million in Q1 2026, from $29.1 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $59.2 million in Q2 2024 to a low of $26.4 million in Q3 2025.
- A 5-year average of $37.9 million and a median of $35.7 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses surged 44.64% in 2024 and tumbled 45.31% in 2025, its largest moves.
- Tracing OMER's Operating Expenses over 5 years: stood at $40.1 million in 2022, then decreased by 0.93% to $39.8 million in 2023, then dropped by 16.12% to $33.4 million in 2024, then dropped by 12.81% to $29.1 million in 2025, then declined by 6.08% to $27.3 million in 2026.
- Business Quant data shows OMER's Operating Expenses at $27.3 million in Q1 2026, $29.1 million in Q4 2025, and $26.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -919.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 445.22 Mn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | 27.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.31 Mn |
| Dec 31, 2025 | 29.08 Mn |
| Sep 30, 2025 | 26.39 Mn |
| Jun 30, 2025 | 32.35 Mn |
| Mar 31, 2025 | 34.97 Mn |
| Dec 31, 2024 | 33.36 Mn |
| Sep 30, 2024 | 35.41 Mn |
| Jun 30, 2024 | 59.16 Mn |
| Mar 31, 2024 | 39.03 Mn |
| Dec 31, 2023 | 39.77 Mn |
| Sep 30, 2023 | 48.15 Mn |
| Jun 30, 2023 | 40.90 Mn |
| Mar 31, 2023 | 35.71 Mn |
| Dec 31, 2022 | 40.14 Mn |
| Sep 30, 2022 | 50.77 Mn |
| Jun 30, 2022 | 37.44 Mn |
| Mar 31, 2022 | 35.05 Mn |
| Dec 31, 2021 | 42.89 Mn |
| Sep 30, 2021 | 39.83 Mn |
| Jun 30, 2021 | 45.61 Mn |